A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
WCSM/WCH continues to pursue the philosophy of “Care and Service” with the spirit of “serving humanity, exploring science and pursuing excellence”. It strives to uphold the motto of the hospital – “Morals, distinction, knowledge, truth, innovation and excellence” by serving its homeland and world with selfless dedication. WCSM/WCH forges ahead towards the goal of establishing itself as an internationally acclaimed center of research and clinical excellence.
Chengdu, China Clinical Trial Location
West China Hospital, Sichuan University
Cuiping Rd, Qianwei County,
Leshan, Sichuan, China